Literature DB >> 24570604

Attitudes and motivations of competitive cyclists regarding use of banned and legal performance enhancers.

Nkaku R Kisaalita1, Michael E Robinson2.   

Abstract

Drug 'doping' and the use of banned performance enhancing products (PEPs) remains an issue in virtually all competitive sports despite penal consequences and known health risks. The lines distinguishing "fair" and "unfair" performance enhancement have become increasingly blurred. Few studies have explored how attitudes towards legal performance enhancers (drugs/substances, diet, and equipment modifications) may influence motivations to use banned PEPs. In the present study, 68 competitive cyclists completed a survey examining the importance of choosing banned and non-banned PEPs using World Anti-Doping Agency (WADA) and Union Cycliste Internationale (UCI) criteria. Results showed that over 60 percent of cyclists used non-banned PEPs while 8 percent used banned PEPs. Health was overall the most important factor in choosing a PEP while apprehension by a doping agency was least important. Mixed- model ANOVA analyses revealed that motivations to use banned PEPs were complex, as the importance of health, violating the sprit of the sport, performance improvement, and getting caught were differentially influenced by PEP legality (p < 0.001) and whether a cyclist endorsed non-banned PEP use (p < 0.001). The importance of winning, sponsorship, and maintaining competitiveness did not influence non-banned PEP use (p > 0.05). Our findings illustrate the multifactorial nature of PEP use/doping attitudes and highlight the unique role that "legal" performance enhancement may plays in influencing banned and/or unethical sports behaviors. Key PointsUse of performance enhancers is high even among non-professional athletesCyclists overall rated "risk to health" as the most important factor in choosing to use a performance enhancing product.Motivations to use banned performance enhancer are complex and are significantly influenced by whether an athlete utilizes "legal" performance enhancers.

Entities:  

Keywords:  Doping; WADA; ethics; health; sports

Year:  2014        PMID: 24570604      PMCID: PMC3918566     

Source DB:  PubMed          Journal:  J Sports Sci Med        ISSN: 1303-2968            Impact factor:   2.988


  22 in total

Review 1.  A conceptual framework for achieving performance enhancing drug compliance in sport.

Authors:  Robert J Donovan; Garry Egger; Vicki Kapernick; John Mendoza
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

2.  Cyclist's doping associated with cerebral sinus thrombosis.

Authors:  José Manuel Martínez Lage; Carlos Panizo; José Masdeu; Eduardo Rocha
Journal:  Neurology       Date:  2002-02-26       Impact factor: 9.910

3.  Self-reported attitudes of elite athletes towards doping: differences between type of sport.

Authors:  A Alaranta; H Alaranta; J Holmila; P Palmu; K Pietilä; I Helenius
Journal:  Int J Sports Med       Date:  2006-02-01       Impact factor: 3.118

4.  Doping prevalence among preadolescent athletes: a 4-year follow-up.

Authors:  P Laure; C Binsinger
Journal:  Br J Sports Med       Date:  2007-05-01       Impact factor: 13.800

5.  Ethics of technologically constructed hypoxic environments in sport.

Authors:  S Loland; A Caplan
Journal:  Scand J Med Sci Sports       Date:  2008-08       Impact factor: 4.221

Review 6.  The rush to adrenaline: drugs in sport acting on the beta-adrenergic system.

Authors:  E Davis; R Loiacono; R J Summers
Journal:  Br J Pharmacol       Date:  2008-06       Impact factor: 8.739

Review 7.  Doping in competition or doping in sport?

Authors:  Giuseppe Lippi; Massimo Franchini; Gian Cesare Guidi
Journal:  Br Med Bull       Date:  2008-04-01       Impact factor: 4.291

8.  Is abstinence an alternative? Predicting adolescent athletes' intentions to use performance enhancing substances.

Authors:  Tonya Dodge; James J Jaccard
Journal:  J Health Psychol       Date:  2008-07

9.  A systemic model of doping behavior.

Authors:  Michael B Johnson
Journal:  Am J Psychol       Date:  2011

10.  Health and doping in elite-level cycling.

Authors:  V Lentillon-Kaestner; M S Hagger; S Hardcastle
Journal:  Scand J Med Sci Sports       Date:  2011-03-10       Impact factor: 4.221

View more
  7 in total

1.  Challenges to promoting health for amateur athletes through anti-doping policy.

Authors:  April Henning
Journal:  Drugs (Abingdon Engl)       Date:  2016-07-22

2.  Doping Attitudes and Covariates of Potential Doping Behaviour in High-Level Team-Sport Athletes; Gender Specific Analysis.

Authors:  Damir Sekulic; Enver Tahiraj; Milan Zvan; Natasa Zenic; Ognjen Uljevic; Blaz Lesnik
Journal:  J Sports Sci Med       Date:  2016-12-01       Impact factor: 2.988

3.  Reply to letter to editor: stereotypes of athletes' use of performance enhancing products.

Authors:  Nkaku Kisaalita; Michael E Robinson
Journal:  J Sports Sci Med       Date:  2014-05-01       Impact factor: 2.988

4.  Cross-cultural adaptation and validation of the spanish version of the performance enhancement attitude scale (petróczi, ).

Authors:  Jaime Morente-Sánchez; Pedro Femia-Marzo; Mikel Zabala
Journal:  J Sports Sci Med       Date:  2014-05-01       Impact factor: 2.988

5.  Stereotypes of athletes' use of performance enhancing products.

Authors:  Carra Johnson; Ronald J Peters
Journal:  J Sports Sci Med       Date:  2014-05-01       Impact factor: 2.988

6.  Examination of Factors Explaining Coaching Strategy and Training Methodology as Correlates of Potential Doping Behavior in High-Level Swimming.

Authors:  Silvester Liposek; Natasa Zenic; Jose M Saavedra; Damir Sekulic; Jelena Rodek; Miha Marinsek; Dorica Sajber
Journal:  J Sports Sci Med       Date:  2018-03-01       Impact factor: 2.988

7.  Doping Prevalence in Competitive Sport: Evidence Synthesis with "Best Practice" Recommendations and Reporting Guidelines from the WADA Working Group on Doping Prevalence.

Authors:  John Gleaves; Andrea Petróczi; Dirk Folkerts; Olivier de Hon; Emmanuel Macedo; Martial Saugy; Maarten Cruyff
Journal:  Sports Med       Date:  2021-04-26       Impact factor: 11.136

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.